Alnylam Pharmaceuticals Inc (ALNY)
280.96
-9.74
(-3.35%)
USD |
NASDAQ |
Mar 25, 16:00
280.77
-0.19
(-0.07%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Liabilities (Quarterly): 4.173B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 124.90B |
| Biomarin Pharmaceutical Inc | 1.331B |
| BridgeBio Pharma Inc | 2.377B |
| Regeneron Pharmaceuticals Inc | 8.406B |
| Vertex Pharmaceuticals Inc | 6.124B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.240B |
| Shareholders Equity (Quarterly) | 67.09M |
| Debt to Equity Ratio | 15.27 |
| Current Ratio | 2.778 |
| Net Debt Paydown Yield | -0.00% |